We concluded that the combination of CD66b+ tumor‐associated neutrophils and α‐SMA+ cancer‐associated fibroblasts could be used as an independent factor of outcome and to identify those gastric adenocarcinoma patients who might obtain advantage from postoperative chemotherapeutics. Here, ACTA1 is linked to gastric adenocarcinoma.